Everest Group Ltd. closed 14.68% short of its 52-week high of $407.30, which the company achieved on October 4th.

BMO Capital Markets downgraded Everest Group (NYSE:EG) to Market Perform from Outperform since the company has become more of ...

Everest Group's underperformance, reserve increase, CEO changes, and potential for growth, prompting a buy rating with $389 ...

Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024. This designation underscores Oracle's ...

Shares of Everest Group Ltd. shed 4.34% to $351.51 Wednesday, on what proved to be an all-around dismal trading session for ...

BMO Capital downgraded Everest Group (EG) to Market Perform from Outperform with a price target of $375, down from $453. The firm says its ...

Everest Group (EG) estimated full-year net income and operating income, revealed reserve developments, and announced new ...

Everest Group Ltd. reported US$1.7 billion in unfavorable prior-year casualty loss development as part of its preliminary ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $432.36, ...

Bermudian-based Everest Group Ltd expects to report full-year 2024 net income in the range of $1.3 billion to $1.4 billion, ...

Global re/insurer Everest Group, Ltd. has revealed that it expects to record full year 2024 net income of between $1.3 ...

HAMILTON, Bermuda, January 27, 2025--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions ...